3328
A Comprehensive Preclinical Characterization Of BMS-986368, A First-in-class, Oral, Dual Inhibitor Of FAAH/MAGL
Kevin Dines, Kate Paget, Marcos Steinberg, Yingzhuo Grace Yan, Iliana Ruiz, Carlos Lopez, Stephanie Smith, Justin Cisar, Jason Clapper, Gary O’Neill, Cheryl A. Grice, Cassie Henry, Alicia Re...
Bristol Myers Squibb, Princeton, NJ, Bristol Myers Squibb, Princeton, NJ; HireGenics, Atlanta, GA, Abide Therapeutics; now Lundbeck La Jolla Research Center, San Diego, CA, Bristol Myers Squibb, Princeton, NJ (...
Poster Presenter: Kevin Dines